A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

The commercialisation of junk food, increase in inactive lifestyles with prolonged sitting, and high stress environments, ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cance ...

A new report noted that body mass index does not provide a nuanced enough assessment of health as it relates to weight ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Simple lifestyle changes can significantly reduce the risks of chronic diseases like heart disease, diabetes, and obesity. By ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...